Company

Bristol Myers Squibb Company

430 East 29th Street
New York, NY 10016
United States






Bristol Myers Squibb Company ( BMY)

Company > Health Care > Major Pharmaceuticals

     LAST CLOSE
            

      $ 64.68 (+ 1.2)

     TRADING VOLUME
           

       12,306,682

     MARKET CAP
            

      $ 105.6B

     52-WEEK HIGH/LOW
           

      $ 55.1 - $66.74









     PREVIOUS    ESTIMATE

                2020           2021

          $ 0 | -

     P/E RATIO    P/E RATIO

             Trailing           Forward

           0 | -

     P/E RATIO    P/E RATIO

             Trailing           Forward

           - | -

     P/E RATIO    P/E RATIO

             Trailing           Forward

           - | -











BMY
S&P 500
     30-DAY CHANGE

          4.36%
           1.95%

     90-DAY CHANGE

          6.17%
           6.96%

180-DAY CHANGE

          1.38%
           18.46%

52-WEEK CHANGE

          5.81%
           44.29%









     DIVIDEND

      0.45

   DIVIDEND YIELD

0.7%

OUTSTANDING

1,632,198,774

50-DAY AVG VOLUME

8913744.06









     FISCAL YEAR END

     
      Dec 31

     Last Earning Date

     
      Feb 04, 2021

     EX-DIVIDEND DATE

     
      Jan 02, 2020

     EX-DIVIDEND DATE

     
      Jan 02, 2020

Ratios

      BOOK VALUE
            

      $8.63

      DEBT TO EQUITY
            

      0.4

      RETURN ON EQUITY
            

      34.83%

Stock Price Chart +

Quarterly Returns +

Year 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Q1 - -12.7 -8.3 3.9 -6.3 -6.6 9.3 -2.3 27.8 -3.3 -
Q2 - 5.5 -3.2 -10.2 3.2 15.8 3.8 -6 9.5 7.1 -
Q3 - 2.7 10.7 13.3 15.2 -26.7 -10 6.3 4.1 -5.5 -
Q4 - 1.9 25.1 -15.8 -4.5 9.1 16.8 16.9 16.5 -2.9 -

Monthly Returns +

Year Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2021 - - - - - - - - - - - -
2020 -1.12 -8.45 -3.58 9.1 -1.79 -1.54 -0.24 6.03 -2.89 -3.98 7.59 -1.35

Annual Returns +

Year 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009
Returns17%-26%-52%29%-7%-6%20%5%-6%15%
Year 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
Returns9%39%-4%70%14%19%-13%8%-13%24%-4%5%

Financial Statements

View More


Income Statement


Millions of US $ except per share data 2020-12-312019-12-312018-12-31
Revenue 425182614522561
Cost Of Goods Sold 1177380786547
Gross Profit 307451806716014

Balance Sheet


Millions of US $ except per share data 2020-12-312019-12-312018-12-31
Cash On Hand 15831-8884
Notes And Loans Receivable ---
Inventory 2074-1195

Cash Flow Statement


Millions of US $ except per share data 2020-12-312019-12-312018-12-31
Net Income/Loss -8995-4947
Total Depreciation And Amortization - Cash Flow 10380-637
Other Non-Cash Items 11684-224


Income Statement


Millions of US $ except per share data 2020-12-312020-09-302020-06-30
Revenue 110681054010129
Cost Of Goods Sold 291025022699
Gross Profit 815880387430
Research And Development Expenses 375024992522
SG&A Expenses 272117061628
Other Operating Income Or Expenses -9612915736
Operating Expenses 2151982838502
Operating Income -1045122571627
Total Non-Operating Income/Expense ---
Pre-Tax Income -1045122571627
Income Taxes -4243791707
Income After Taxes -100271878-80
Other Income ---
Income From Continuous Operations -100271878-80
Income From Discontinued Operations ---
Net Income -100271872-85
EBITDA -776149124185
EBIT -1045122571627
Basic Shares Outstanding 225822572263
Shares Outstanding 225822902263
Basic EPS -4.440.83-0.04
EPS - Earnings Per Share -4.430.82-0.04

Balance Sheet


Millions of US $ except per share data 2020-12-312020-09-302020-06-30
Cash On Hand 158312115521658
Notes And Loans Receivable ---
Inventory 207419492384
Other Current Assets 378631112446
Total Current Assets 301923427734343
Property, Plant, And Equipment 588657405777
Long-Term Investments 433495523
Goodwill And Intangible Assets 737907721579749
Other Long-Term Assets 701968966596
Total Long-Term Assets 882899125993733
Total Assets 118481125536128076
Total Current Liabilities 190802046423421
Long Term Debt 483364136441853
Other Non-Current Liabilities 777675657485
Total Long Term Liabilities 615195484255495
Total Liabilities 805997530678916
Common Stock Net 292292292
Retained Earnings (Accumulated Deficit) 212813241431565
Comprehensive Income -1839-1699-1556
Other Share Holders Equity ---
Share Holder Equity 378825023049160
Total Liabilities And Share Holders Equity 118481125536128076
Receivables 850180627855
Pre-Paid Expenses ---

52-Week High/Low

Annual Earnings







Year Jun Mar Sep Dec Annual
2005 0.27 0.50 0.49 0.26 1.52
2006 0.36 0.34 0.17 -0.06 0.81
2007 0.35 0.36 0.43 -0.05 1.09
2008 0.33 0.38 1.28 0.63 2.62
2009 0.32 0.49 0.48 4.05 5.34
2010 0.43 0.53 0.55 0.28 1.79
2011 0.57 0.52 0.56 0.51 2.16
2012 0.64 0.38 -0.43 0.57 1.16
2013 0.37 0.32 0.42 0.43 1.54
2014 0.56 0.20 0.43 0.01 1.2
2015 0.71 0.53 0.39 0.38 2.01
2016 0.74 0.69 0.77 0.63 2.83
2017 0.84 0.74 0.75 0.68 3.01
2018 0.94 1.01 1.09 0.94 3.98
2019 1.10 1.18 1.17 1.22 4.67
2020 - - - - -

Earnings Calendar


Quarter | Rep. Date
2020
| May 07
| Aug 06
Quarter | Rep. Date
2019
Mar | Apr 25
Jun | Jul 25
Sep | Oct 31
Dec | Feb 06
Quarter | Rep. Date
2018
Mar | Apr 26
Jun | Jul 26
Sep | Oct 25
Dec | Jan 24
Quarter | Rep. Date
2017
Mar | Apr 27
Jun | Jul 27
Sep | Oct 26
Dec | Feb 05
Quarter | Rep. Date
2016
Mar | Apr 28
Jun | Jul 28
Sep | Oct 27
Dec | Jan 26

Dividend History


Year Mar Jun Sep Dec Annual
2020 0.45 0.45
2019 0.41 0.41 0.41 0.41 1.64
2018 0.4 0.4 0.4 0.4 1.6
2017 0.39 0.39 0.39 0.39 1.56
2016 0.38 0.38 0.38 1.14

Ex - Dividend Data & Date


Year Mar Jun Sep Dec Annual
2020 Jan 02 | 0.45 0.45
2019 Jan 03 | 0.41 Apr 04 | 0.41 Jul 03 | 0.41 Oct 03 | 0.41 1.64
2018 Jan 04 | 0.4 Apr 05 | 0.4 Jul 05 | 0.4 Oct 04 | 0.4 1.6
2017 Jan 04 | 0.39 Apr 05 | 0.39 Jul 05 | 0.39 Oct 05 | 0.39 1.56
2016 Mar 30 | 0.38 Jun 29 | 0.38 Oct 05 | 0.38 1.14